Table 2.
Co‐infection with viruses and bacteria
| Assessable for bacterial and viral co‐infection (Group 1, n = 93) | Assessable for any co‐infection (Group 2, n = 176) | |
|---|---|---|
| Viruses | ||
| Respiratory syncytical virus | 0 | 1 |
| Parainfluenza virus 3 | 1 | 1 |
| Adenovirus | 1* | 1* |
| Picornavirus | 1 | 3 |
| Total subjects with viral co‐infection (%) | 3 (3·2) | 6 (3·4) |
| Bacteria | ||
| Staphylococcus aureus | 13* | 17* |
| MSSA/MRSA | 9/4 | 11/6 |
| Streptococcus pneumoniae | 7** | 10** |
| Haemophilus influenzae | 3 | 6 |
| Beta haemolytic streptococci | 0 | 2 |
| Pseudomonas aeruginosa | 1** | 2** |
| Bordetella pertussis | 2** | 2** |
| Total subjects with bacterial co‐infection (%) | 23 (24·7) | 36 (20·5) |
| Total subjects with any co‐infection (%) | 25 (26·9) | 41 (23·3) |
MRSA, methicillin resistant S. aureus.
*One patient had co‐infection with Influenza A virus, Human adenovirus and S. aureus.
**Two patients had more than one bacterial co‐infection identified: (i) S. pneumoniae, P. aeruginosa and B. pertussis and (ii) S. pneumoniae and B. pertussis.